Brian Fairchild 
Device-guided breathing stress relief is no longer just a wellness concept. It is a clinically studied outcome backed by peer-reviewed research in some of the most demanding patient populations in medicine. Most people discover RESPeRATE because of high blood pressure. Then they notice something else. Their stress feels lower, their sleep improves, and the tension they carried through the day starts to ease. That is not a coincidence. The FDA cleared RESPeRATE for stress reduction alongside its blood pressure indication, and the clinical evidence behind that clearance runs deeper than most people realize.
How Device-Guided Breathing Lowers Stress at the Source
Stress and high blood pressure share the same trigger. Both start with an overactive sympathetic nervous system.
When the body senses a threat, the sympathetic system fires. Heart rate climbs. Blood vessels tighten. Stress hormones surge. Blood pressure rises as a result.
This reaction is useful in short emergencies. But chronic stress keeps the system running too hot. That sustained overdrive causes real harm over time.
Device-guided breathing (DGB) breaks that cycle at the nerve level. RESPeRATE guides users to five to six breaths per minute. The device gets there by slowly stretching the exhale tone.
At that pace, stretch sensors in the lungs send a calming signal to the brain stem. Muscle sympathetic nerve activity falls during and after each session.
Each DGB session does two things. It lowers blood pressure. It also dials down the nerve overdrive that drives stress, anxiety, and tension.The American Heart Association’s 2013 statement on non-drug approaches to blood pressure gave DGB a Class IIA, Level B recommendation. The AHA also noted no side effects. RESPeRATE is the only device of its type in that statement.
The Clinical Evidence on Device-Guided Breathing and Stress Reduction
The strongest DGB stress research comes from studies on combat veterans with PTSD.
PTSD keeps the sympathetic nervous system in overdrive. It also blunts the body’s blood pressure reflex. That makes PTSD one of the toughest stress conditions to study.
Researchers at Emory University ran two back-to-back sham-controlled trials using RESPeRATE in this group.
The Emory PTSD Trials
The first trial appeared in the American Journal of Physiology in 2018. It enrolled 23 veterans with pre-high blood pressure and PTSD.
The team measured nerve activity, blood pressure, and blood pressure reflex sensitivity. Each participant did one 15-minute DGB session.
The DGB group saw systolic blood pressure fall by about nine points. Muscle nerve activity also dropped. Blood pressure reflex sensitivity improved. The sham group showed none of these changes.
This was the first study to test DGB’s direct nerve effects in PTSD patients.
Citation: Fonkoue et al., 2018 — PubMed
The second trial, published in 2020, ran for eight weeks. Twenty-five veterans used either the active RESPeRATE or a sham device. Each session lasted 15 minutes daily.
Resting blood pressure stayed similar in both groups. But the DGB group showed a clear result. Their sympathetic nerve response to mental stress dropped significantly.
Burst frequency and burst incidence during a mental math stress test were both lower in the DGB group. The researchers concluded that daily DGB damps down stress nerve reactivity over time.
Citation: Fonkoue et al., 2020 — PubMed
Both trials appear on RESPeRATE’s clinical proof page. They rank among the strongest non-drug stress intervention studies of that decade.
It was 150/100, this morning it was 110/79
Watch How Mark Lowered His Blood Pressure Naturally.
DGB, Anxiety, and Stress Across Multiple Populations
Beyond PTSD, researchers have tested DGB for stress and anxiety in several other settings. The results are consistently positive.
Anxiety and Test Stress
A 2022 pilot study in Frontiers in Psychology tested DGB for test anxiety in college students. Students used RESPeRATE daily for three weeks.
The DGB group showed a large drop in reported anxiety compared to controls. Blood pressure also fell. The team noted DGB may help with general anxiety, not just test stress.
Citation: Ovadia-Blechman et al., 2022 — PMC
A 2011 study in Applied Psychophysiology and Biofeedback took a different angle. It tested DGB in patients facing dental procedures. Managing stress in that setting is notoriously hard. DGB reduced anxiety there too.
Citation: Morarend et al., 2011 — PubMed
Caregivers and Cancer Survivors
A University of Colorado team used RESPeRATE as part of a stress program for bone marrow transplant caregivers. This group carries one of the highest stress loads in any caregiving role.
Their 2017 study in Supportive Care in Cancer showed the program worked. Caregiver distress fell. Mental health service use dropped significantly compared to the usual care group.
Citation: Simoneau et al., 2017 — PubMed
A 2023 multi-site feasibility study tested RESPeRATE in lung cancer survivors. These patients reported significant anxiety and shortness of breath after treatment ended.
The RELAX trial ran across community cancer clinics. The DGB group found the device easy to use and stuck with it. Early data supported a drop in anxiety levels.
Citation: Danhauer et al., 2023 — PMC
A 2023 review in Mindfulness pulled together data from many slow-breathing studies. The review confirmed the pattern: slow breathing raises heart rate variability. It reduces stress nerve activity. It improves mood and emotional balance.
Citation: Li et al., 2024 — Springer Nature
Why Device-Guided Breathing Beats Self-Guided Practice
Many people try to slow their breathing when stress hits. Most stop too soon. They never reach the pace where the nerve shift happens.
Effective slow breathing needs a steady rate below 10 breaths per minute. It also needs a long exhale. Most people cannot hold that pace alone, especially under stress.
RESPeRATE solves that problem. The device reads your natural breathing rate. It then guides it down in real time. If you fall out of sync, it adjusts and starts again.
Mental effort stays low by design. That matters. High focus and effort raise stress nerve activity. They can undo the benefit you are trying to create.
Unguided breathing methods like yoga can help. But they demand mental focus that some users find counterproductive. RESPeRATE removes that barrier entirely.
The NIH’s National Heart, Lung, and Blood Institute lists stress reduction as a core part of blood pressure care. RESPeRATE supports that goal as part of your overall health program, alongside your physician-directed treatment plan.
It was 170/110, this morning it was 120/80
Watch how Julie Lowered her Blood Pressure Naturally.
Summary
Device-guided breathing stress relief stands on solid clinical ground. Research in PTSD patients, cancer survivors, caregivers, and anxious dental patients all points the same way.
DGB reduces stress nerve activity. That drop leads to lower stress, less anxiety, and better heart health. The effect is consistent across very different patient groups.
RESPeRATE is the only FDA-cleared device of its kind. Over 50 published studies back it. More than 250,000 people use it. For anyone managing stress and blood pressure together, it offers real clinical support in just 15 minutes a day.
RESPeRATE works best as part of your overall health program alongside your physician-directed treatment plan.
Ready to take a clinically supported step toward lower stress and healthier blood pressure? Shop RESPeRATE today and use it as part of your overall health program, alongside your physician-directed treatment plan.
Clinically proven
Eli 
Comments